Evidence map›Paper›PMID 21978664›Full record

ArticleJournal of molecular biology2011

Heparin activates PKR by inducing dimerization.

Eric Anderson, Willythssa S Pierre-Louis, C Jason Wong, Jeffrey W Lary, James L Cole

Abstract read
In one paragraph

Article in Journal of molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eric AndersonDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, USA.
Willythssa S Pierre-Louis
C Jason Wong
Jeffrey W Lary
James L Cole
University of Connecticut · US

Funding

Mechanism for Activation of the Antiviral Kinase PKRR01AI053615 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI COLE, JAMES L · 2004 to 2016
$3.9M
NIAID NIH HHS AI-53615NIAID NIH HHS R01 AI053615
6 · The paper itself

Abstract

Protein kinase R (PKR) is an interferon-induced kinase that plays a pivotal role in the innate immunity pathway. PKR is activated to undergo autophosphorylation upon binding to double-stranded RNAs or RNAs that contain duplex regions. Activated PKR phosphorylates the α subunit of eukaryotic initiation factor 2, thereby inhibiting protein synthesis. PKR is also activated by heparin, a highly sulfated glycosaminoglycan. We have used biophysical methods to define the mechanism of PKR activation by heparin. Heparins as short as hexasaccharide bind strongly to PKR and activate autophosphorylation. In contrast to double-stranded RNA, heparin activates PKR by binding to the kinase domain. Analytical ultracentrifugation measurements support a thermodynamic linkage model where heparin binding allosterically enhances PKR dimerization, thereby activating the kinase. These results indicate that PKR can be activated by small molecules and represents a viable target for the development of novel antiviral agents.

Indexed as

Binding SiteseIF-2 KinaseEnzyme ActivationHeparinHumansModels, ChemicalPhosphorylationProtein BindingProtein ConformationProtein MultimerizationRNA, Double-StrandedeIF-2 KinaseHeparinRNA, Double-Stranded

Identifiers

PMID21978664
PMCPMC3268052
OpenAlexW2021643601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.